Literature DB >> 23453858

Illuminating CNS and cognitive issues in myotonic dystrophy: Workshop report.

Michelle M Axford1, Christopher E Pearson.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23453858     DOI： 10.1016/j.nmd.2013.01.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  11 in total

1.  Brain MRI abnormalities in the adult form of myotonic dystrophy type 1: A longitudinal case series study.

Authors:  Renata Conforti; Mario de Cristofaro; Adriana Cristofano; Barbara Brogna; Angela Sardaro; Gioacchino Tedeschi; Sossio Cirillo; Alfonso Di Costanzo
Journal:  Neuroradiol J       Date:  2016-01-11

Review 2.  How Research on Human Progeroid and Antigeroid Syndromes Can Contribute to the Longevity Dividend Initiative.

Authors:  Fuki M Hisama; Junko Oshima; George M Martin
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

3.  Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2.

Authors:  Stojan Peric; Vidosava Rakocevic Stojanovic; Gorana Mandic Stojmenovic; Vera Ilic; Masa Kovacevic; Aleksandra Parojcic; Jovan Pesovic; Milija Mijajlovic; Dusanka Savic-Pavicevic; Giovanni Meola
Journal:  Neurol Sci       Date:  2016-11-28       Impact factor: 3.307

Review 4.  Congenital myotonic dystrophy: ventriculomegaly and shunt considerations for the pediatric neurosurgeon.

Authors:  Ian S Mutchnick; Meena A Thatikunta; William C Gump; Dan L Stewart; Thomas M Moriarty
Journal:  Childs Nerv Syst       Date:  2016-01-08       Impact factor: 1.475

5.  Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2).

Authors:  Chad Heatwole; Nicholas Johnson; Rita Bode; Jeanne Dekdebrun; Nuran Dilek; James E Hilbert; Elizabeth Luebbe; William Martens; Michael P McDermott; Christine Quinn; Nan Rothrock; Charles Thornton; Barbara G Vickrey; David Victorson; Richard T Moxley
Journal:  Neurology       Date:  2015-11-18       Impact factor: 9.910

Review 6.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

7.  Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).

Authors:  Stéphane Jean; Louis Richer; Luc Laberge; Jean Mathieu
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

8.  Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage.

Authors:  Francesca Caso; Federica Agosta; Stojan Peric; Vidosava Rakočević-Stojanović; Massimiliano Copetti; Vladimir S Kostic; Massimo Filippi
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

Review 9.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

10.  Variant repeats within the DMPK CTG expansion protect function in myotonic dystrophy type 1.

Authors:  Jacob N Miller; Ellen van der Plas; Mark Hamilton; Timothy R Koscik; Laurie Gutmann; Sarah A Cumming; Darren G Monckton; Peggy C Nopoulos
Journal:  Neurol Genet       Date:  2020-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.